Related Experiment Video
Updated: Apr 17, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
[Selected aspects of oral contraception side effects]
Oral contraception, while widely used, carries risks like venous thromboembolism (VTE) and impacts lipid profiles. Understanding these side effects is crucial for safe use and monitoring.
Area of Science:
- Reproductive Health
- Endocrinology
- Pharmacology
Context:
- Oral contraceptives (OCs) have been a global standard for birth control since the 1960s.
- Their widespread use is attributed to availability, ease of use, and perceived safety.
- However, significant side effects necessitate careful consideration.
Purpose:
- To review the most frequent side effects associated with oral contraception.
- To outline methods for monitoring and diagnosing these adverse events.
- To inform healthcare providers and patients about potential risks.
Summary:
- Oral contraception is linked to an increased risk of venous thromboembolism (VTE), influenced by estrogen dose and progestin generation.
- Progestins in OCs can negatively affect lipid profiles, decreasing HDL and increasing LDL and total cholesterol.
- Estrogens may contribute to an increased risk of breast cancer due to their mitogenic effects on mammary gland tissue.
- Common subjective side effects include headaches, mood changes, nausea, pain, and decreased libido.
- Hereditary thrombophilia significantly elevates VTE risk in women using OCs.
Impact:
- Highlights the importance of risk assessment, particularly for women with hereditary thrombophilia.
- Emphasizes the need for patient education regarding potential side effects and when to seek medical advice.
- Supports informed decision-making for individuals considering or using oral contraceptives.
- Underscores the role of monitoring lipid profiles and VTE risk factors in OC users.
More Related Videos
06:22Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis
Published on: September 1, 2019
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
Related Concept Videos
Birth Control Methods
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Ovarian Cycle
Intrauterine Drug Delivery Systems
Menopause